(Q48607713)

13 February 2018

title

Basal ganglia volumes in first-episode schizophrenia and healthy comparison subjects (English)

1 reference

13 February 2018

0 references

9

John Kane

1 reference

13 February 2018

Jeffrey Lieberman

8

object named as

Jeffrey Lieberman

1 reference

13 February 2018

author name string

Handan Gunduz

1

1 reference

13 February 2018

Huwei Wu

2

1 reference

13 February 2018

Manzar Ashtari

3

1 reference

13 February 2018

Bernhard Bogerts

4

1 reference

13 February 2018

David Crandall

5

1 reference

13 February 2018

Delbert G Robinson

6

1 reference

13 February 2018

Jose Alvir

7

1 reference

13 February 2018

Robert Bilder

10

1 reference

13 February 2018

language of work or name

English

0 references

publication date

1 May 2002

1 reference

13 February 2018

published in

Biological Psychiatry

1 reference

13 February 2018

volume

51

1 reference

13 February 2018

issue

10

1 reference

13 February 2018

page(s)

801-808

1 reference

13 February 2018

Computerized volume measurement of brain structure.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901345-2

The pathomorphology of schizophrenia and mood disorders: similarities and differences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901345-2

Reduced volume of limbic system-affiliated basal ganglia in mood disorders: preliminary data from a postmortem study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901345-2

Neurocognitive impairment in schizophrenia and how it affects treatment options

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901345-2

Post-mortem volume measurements of limbic system and basal ganglia structures in chronic schizophrenics. Initial results from a new brain collection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901345-2

Basal ganglia and limbic system pathology in schizophrenia. A morphometric study of brain volume and shrinkage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901345-2

Brain morphology and schizophrenia. A magnetic resonance imaging study of limbic, prefrontal cortex, and caudate structures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901345-2

Positron emission tomography studies of basal ganglia and somatosensory cortex neuroleptic drug effects: differences between normal controls and schizophrenic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901345-2

Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901345-2

Dual cytoarchitectonic trends: an evolutionary model of frontal lobe functioning and its application to psychopathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901345-2

Caudate size in first-episode neuroleptic-naive schizophrenic patients measured using an artificial neural network

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901345-2

Brain morphology in first-episode schizophrenic-like psychotic patients: a quantitative magnetic resonance imaging study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901345-2

Positron emission tomography in schizophrenic patients with and without neuroleptic medication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901345-2

Childhood-onset schizophrenia: brain MRI rescan after 2 years of clozapine maintenance treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901345-2

Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901345-2

Basal forebrain in the context of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901345-2

Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901345-2

Caudate, putamen, and globus pallidus volume in schizophrenia: a quantitative MRI study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901345-2

Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901345-2

Magnetic resonance imaging abnormalities in lenticular nuclei and cerebral cortex in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901345-2

Choline acetyltransferase in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901345-2

Changes in caudate volume with neuroleptic treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901345-2

Schizophrenic symptoms and cerebral pathology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901345-2

In vivo stereological assessment of caudate volume in man: effect of normal aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901345-2

Magnetic resonance imaging of the caudate nuclei in depression. Preliminary observations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901345-2

An MRI study of basal ganglia volumes in first-episode schizophrenia patients treated with risperidone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901345-2

Dopamine receptor mRNA expression in human striatum and neocortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901345-2

Effect of antipsychotics on regional cerebral blood flow measured with positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901345-2

The assessment and analysis of handedness: The Edinburgh inventory

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901345-2

Magnetic-resonance morphometry in patients with major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901345-2

The case of frontostriatal dysfunction in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901345-2

Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901345-2

Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901345-2

Clinicopathologic correlations in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901345-2

Subcortical and temporal structures in affective disorder and schizophrenia: a magnetic resonance imaging study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901345-2

Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901345-2

Cholinergic hyperactivity and negative schizophrenic symptoms. A model of cholinergic/dopaminergic interactions in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901345-2

Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901345-2

10.1016/S0006-3223(01)01345-2

7 January 2021

Identifiers

DOI

1 reference

13 February 2018

1 reference

13 February 2018